Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0KT5W
|
|||
Drug Name |
PMID25656651-Compound-30b
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
PIRAMAL HEALTHCARE LIMITED SIVAKUMAR, Meenakshi JOSHI, Kalpana Sanjay AWARE, Valmik Sopan SARDE, Ankush Gangaram BAGUL, Sandeep Mukunda MANOHAR, Sonal Mohan
|
|||
Structure |
Download2D MOL |
|||
Formula |
C17H14N2O3
|
|||
Canonical SMILES |
C1=CC=C(C=C1)CC2=NOC(=N2)C=CC3=CC(=C(C=C3)O)O
|
|||
InChI |
1S/C17H14N2O3/c20-14-8-6-13(10-15(14)21)7-9-17-18-16(19-22-17)11-12-4-2-1-3-5-12/h1-10,20-21H,11H2/b9-7+
|
|||
InChIKey |
BJLAYSATLVCCDW-VQHVLOKHSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fusion protein Bcr-Abl (Bcr-Abl) | Target Info | Inhibitor | [1] |
Target's Patent Info | Fusion protein Bcr-Abl (Bcr-Abl) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.